Drugs Used to Treat Myositis - A Joint and Muscle Disease
Scholars Research Library

Scholars Research Library

A-Z Journals

+44 7389645282

Der Pharmacia Lettre

Commentary - Der Pharmacia Lettre ( 2023) Volume 15, Issue 2

Drugs Used to Treat Myositis - A Joint and Muscle Disease

Ronald George*
Department of Pharmacology, University of Jawaharlal Nehru, New Delhi, India
*Corresponding Author:
Ronald George, Department of Pharmacology, University of Jawaharlal Nehru, New Delhi, India, Email:

Received: 01-Feb-2023, Manuscript No. DPL-23-91673; Editor assigned: 06-Feb-2023, Pre QC No. DPL-23-91673(PQ); Reviewed: 20-Feb-2023, QC No. DPL-23-91673; Revised: 27-Feb-2023, Manuscript No. DPL-23-91673(R); Published: 06-Mar-2023 , DOI: 10.37532/dpl.2023.15.05


One variety of myopathy is myositis. Myopathies are a collective name for illnesses that affect the muscles that attach to the bones (skeletal muscles). A disorder called myositis causes the immune system to assault the muscles. It results in swelling that fluctuates over a lengthy period of time due to chronic inflammation. This inflammation eventually makes one’s muscles feel weaker and weaker. Muscle soreness can also result from it. The entire body is affected by several types of myositis, which affect various muscle groups. The muscles that are used to move, such as those in the arms, shoulders, legs, spine and abdomen and hips, are typically affected by myositis. The different forms of myositis includes: Polymyositis, Dermatomyositis, Inclusion body myositis.


Polymyositis simultaneously impacts several muscles. Typically, the muscles on or close to the body's core experience problems. With time, polymyositis steadily worsens. Adults are frequently affected. In comparison to men and people assigned male at birth, polymyositis affects women and those who were assigned female at birth twice as frequently. A person having polymyositis could find it difficult to execute actions that are normally taken for granted, such as standing up after sitting, ascending stairs, lifting things.


Dermatomyositis is a form of myositis that affects both the skin and muscles. Dermatomyositis can develop rapidly, however some cases take months to manifest. The earlier a patient suffering from dermatomyositis starts the therapy, the more probable it is that he won't experience serious consequences. Occasionally, dermatomyositis causes death, especially in the first year after the onset of symptoms. Also, it may be more likely to lead to have some types of cancer. Dermatomyositis can affect anyone. Juvenile dermatomyositis is the name given to it when it affects children.

Inclusion body myositis

Inclusion body myositis is one type of degenerative muscle disease. Typically, those over 50 are affected. Muscle wasting in extremities is brought on by inclusion body myositis (hands and legs below the knees). The muscles in the throat that aid in swallowing may also be impacted. Dysphagia affects about 30% of those who have inclusion body myositis (difficulty swallowing). If a person has inclusion body myositis, it could be challenging to grasp something small, using hands and fingers to perform precise tasks like buttoning a shirt, swallow, walk or stand.

The immune system is suppressed by many myositis medications. With autoimmune illnesses like myositis, the body produces antibodies that target its own tissues as invaders rather than battling external infections. The medications that assist in the suppression of myositis activity by partially reducing immune system activity include:

Corticosteroids are extremely potent medications. Corticosteroids (drugs that mimic cortisone) are used to treat inflamed body regions. They reduce allergic reactions' itching, swelling, and other symptoms of inflammation. They are frequently used as a component of the treatment for a variety of illnesses, including severe allergies or skin conditions, asthma, or arthritis.

Azathioprine is an anti-inflammatory drug for the treatment of rheumatoid arthritis and other inflammatory diseases. The blood cells that bring about inflammation are suppressed as a result of it. Azathioprine is used to lessen the signs and symptoms of rheumatoid arthritis, including the duration and severity of morning stiffness, joint pain, and edoema. Imuran is the brand name by which azathioprine is frequently referred to.

Methotrexate is one of the most widely used and successful therapies for rheumatoid arthritis and other inflammatory forms of arthritis, and is also occasionally used to treat lupus, inflammatory myositis, vasculitis, and various types of juvenile arthritis. To treat arthritis, it is frequently taken in conjunction with several drugs. It is referred to as a Disease-Modifying Anti-Rheumatic Medication (DMARD) because it can lessen joint deterioration and long-term impairment in addition to reducing the pain and swelling associated with arthritis.

Immunoglobulin, commonly known as Ig or gamma globulin, is a term used to describe the liquid plasma portion of blood, which contains immunoglobulins or antibodies. A complicated series of actions involving other immune system elements are triggered when antibody molecules physically connect to a pathogen that they identify as alien and begin to physically recognise as such. This process eventually results in the eradication of the infection. Antibodies included in immune globulin strengthens the immune system. Patients with Primary humoral Immunodeficiency (PI), Idiopathic Thrombocytopenic Purpura (ITP), Chronic Immune Thrombocyto Penic Purpura (CITPP), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), or Dermato Myositis (DM) may benefit from it.

Myositis is a condition that can manifest in many different ways and that doesn't just impact the muscles; it can also affect the entire body. This can make it difficult to make a diagnosis, but thorough evaluation utilising all the instruments at hand can do so and, perhaps, will make it simpler in the years to come. Although there is no known cure for myositis, the majority of people can manage their symptoms using current therapies. Also, the speed of research in this field is accelerating, which should soon lead to the development of new therapies and improved outcomes for myositis patients.